When should microscopy be enough without NAAT?

When experienced microscopy is immediately available and classic findings are unequivocal—motile trichomonads, abundant clue cells with positive whiff and pH >4.5 for BV, or pseudohyphae on KOH for candidiasis—many pathways still add NAAT for trichomoniasis and STI cotesting because mixed infection is common and wet mounts miss a meaningful minority.

How soon after oral metronidazole is alcohol safe?

Avoid alcohol through the nitroimidazole course and for at least 48–72 hours after the last dose per formulary and manufacturer guidance; document the interaction and reassess if the patient reports flushing, tachycardia or vomiting suggestive of a disulfiram-like reaction.

Does treating trichomoniasis require partner therapy?

Yes—trichomoniasis is sexually transmitted; concurrent treatment of all sex partners, abstinence until therapy is completed, and retesting per national guideline intervals reduce recurrence and onward transmission.

What defines recurrent vulvovaginal candidiasis?

Typically four or more symptomatic episodes within 12 months after specialist confirmation; these patients need longer suppressive azole strategies and evaluation for diabetes, immunosuppression or non-albicans species—not repeated short courses without reassessment.

Should I link every malodorous discharge to BV alone?

No—trichomoniasis and aerobic vaginitis can also produce offensive discharge; NAAT or microscopy plus risk history prevents anchoring on BV when cervicitis or mixed infection is present.

When does dysuria point away from simple vaginitis?

Internal dysuria with fever, flank pain or new haematuria should trigger urinary tract infection pathways and urgent assessment; external burning with intact urinalysis more often tracks with vulvitis or candidiasis.

How do pregnancy pathways differ for vaginitis?

Symptomatic BV in pregnancy is treated per obstetric infectious disease guidance with documented regimens; oral fluconazole high-dose protocols used outside pregnancy are generally avoided in the first trimester—align azole choice with prescriber and local formulary.

What follow-up interval after first-line therapy?

Clinical review at 1–2 weeks when symptoms were moderate, sooner if pregnancy, immunocompromise or treatment failure; persistent discharge after two directed courses warrants expanded NAAT, culture and consideration of cervicitis or foreign body.

Vaginitis: Causes, Symptoms, Treatment & Prevention | NurseOnShift

🩺 Gynecological · Infectious disease

Vaginitis: Causes, Symptoms, Treatment & Prevention

Shift-ready synthesis for nurses: sort discharge pattern triage across BV, vulvovaginal candidiasis and trichomoniasis, time microscopy or NAAT cadence with guideline-aligned first-line therapy, and recognise when PID or sepsis overrides outpatient teaching.

⏱️24 min read

📅Updated May 17, 2026

✓Medically Reviewed

✍️

Written by

Sid Ahmed Abdala Balal

RGN

🩺

Reviewed by

Dr. Harriet Blundell

MBBS, MSc, MD

✨

Featured snippet

Vaginitis is inflammation or infection of the vagina—most often from bacterial vaginosis (BV), vulvovaginal candidiasis or trichomoniasis—presenting with vaginal discharge, odour, itch or soreness. Bedside triage pairs discharge pattern with vaginal pH, microscopy when available, and increasingly NAAT to catch mixed infection. First-line therapy follows national STI / gynaecology pathways (nitroimidazoles for BV and trichomoniasis; azoles for candidiasis); fever with pelvic pain should trigger PID escalation rather than another unsupervised antibiotic course.

🔑Key Takeaways

Anchor triage on discharge + pH + itch: thin malodorous discharge with elevated pH suggests bacterial vaginosis; curd-like pruritus with normal pH fits vulvovaginal candidiasis; frothy yellow-green discharge with motile flagellates or positive NAAT flags trichomoniasis—an STI needing partner treatment.
Use a clear microscopy or NAAT cadence: wet mount and KOH when skilled microscopy exists; add NAAT where trichomoniasis is easy to miss or co-infection is likely; coordinate specimen collection with laboratory standards.
First-line antimicrobials align with CDC / WHO sexual-health guidance: metronidazole (or tinidazole where available) for BV and trichomoniasis; fluconazole or topical clotrimazole for uncomplicated candidiasis; clindamycin intravaginally when nitroimidazole avoidance is documented.
Overlap gonorrhoea / cervicitis risk: gonorrhoea and mucopurulent cervicitis can coexist with vaginitis—new pelvic pain or fever should pivot to pelvic inflammatory disease pathways.
Recurrent vulvovaginal candidiasis prompts screening for type 2 diabetes and polycystic ovary syndrome; recurrent BV benefits from douching cessation and sexual-health review.

⚡ Quick Facts

📊

Office visits

Millions yearly (US)

📍

BV pH threshold

>4.5 typical

⏱️

NAAT sensitivity

Higher vs wet mount

⚠️

RVC definition

≥4 episodes / 12 mo

💡 Clinical Pearl

Patients often self-treat repeated “thrush” while harbouring trichomoniasis or BV; a single NAAT panel can reset the trajectory before chronic topical steroid or azole exposure masks examination findings.

📑 Contents

❓

What is Vaginitis?

Vaginitis describes inflammatory or infectious processes of the vaginal mucosa producing vaginal discharge, odour, burning or genital itching. Lactobacillus-dominant flora normally maintains an acidic pH; loss of that milieu permits anaerobic overgrowth (BV), yeast proliferation (candidiasis) or introduction of Trichomonas vaginalis. Non-infectious triggers—contact irritants, atrophic change, desquamative or inflammatory subsets—sit in the same symptom cluster and explain treatment failures when antibiotics alone are deployed.

Because millions of clinical encounters each year centre on vaginal symptoms, nurses add value by structuring history (menses, contraception, antibiotics, sexual partners), interpreting point-of-care tests, reinforcing microscopy or NAAT cadence, and documenting safety-net advice for pregnancy or immunosuppression.

📊

Syndrome patterns (BV, candidiasis, trichomoniasis)

Feature	Bacterial vaginosis	Vulvovaginal candidiasis	Trichomoniasis
Discharge	Thin grey-white homogeneous; malodorous discharge “fishy”	Thick “cottage cheese”, minimal odour	Yellow-green frothy; offensive
pH (vaginal)	>4.5	Usually ≤4.5	Often >4.5
Microscopy	Clue cells, positive whiff	Pseudohyphae on KOH	Motile trichomonads
STI implications	Risk associations; treat symptomatic disease	Not sexually acquired in typical VVC	Treat partners; retest

On narrow screens, scroll sideways to compare discharge, pH and microscopy or NAAT clues.

🚨Do not miss

Fever, rigors, rebound tenderness or purulent cervical discharge with systemic symptoms—think PID or sepsis, not outpatient vaginitis alone.
Pregnancy with abdominal pain, uterine tenderness or fetal tachycardia—obstetric emergency pathway.
Haematuria with flank pain—urinary tract focus; see urinary tract infection workup.

🔍

Symptoms

Typical clusters mirror the table above: odour-predominant thin discharge (BV), intense pruritus with external dysuria (candidiasis), or frothy malodorous discharge with vulvar irritation (trichomoniasis). Atypical presentations include post-coital spotting when cervicitis coexists, minimal discharge in early atrophic change, or coincident genital herpes ulceration that redirects attention from underlying vaginitis.

🦠

Causes and Risk Factors

BV reflects replacement of lactobacilli by anaerobic flora; risk includes new partners, douching and intrauterine devices in some cohorts. Candidiasis follows candidal overgrowth after antibiotics, hyperglycaemia or oestrogen-rich states. Trichomoniasis is sexually transmitted. Non-infectious irritants (soaps, pads, latex) mimic infection until examination and pH testing redirect care.

🔬

How is it Diagnosed?

Clinical assessment

External inspection, speculum assessment of discharge and cervix, bimanual examination when pain is present, and risk history for STI coinfection.

Office tests

pH paper on lateral vaginal wall (not cervical mucus).
Whiff test (10% KOH) when BV suspected.
Wet mount / KOH if microscopy turnaround is rapid.
NAAT for T. vaginalis when wet mount unavailable or symptoms discordant.

Cervical screening context

Align symptomatic visits with local policy on whether to defer routine Pap smear until infection clears, avoiding obscured cytology.

Imaging when pelvic pain dominates

Where PID or tubo-ovarian abscess is suspected, clinicians may request transvaginal ultrasound—nurses prepare patients, obtain vitals and escalate positive sepsis screens.

🧠

Differential Diagnoses

Bacterial vaginosis, vulvovaginal candidiasis, trichomoniasis (classic triad).
Pelvic inflammatory disease and gonorrhoea cervicitis when cervical motion tenderness or systemic signs appear.
Urinary tract infection when dysuria is internal with pyuria.
Genital herpes first episode with painful ulcers.

💊

Treatment Options

Selection follows confirmed or high-probability syndrome per CDC STI Treatment Guidelines and WHO syndromic modules. BV: oral or vaginal metronidazole; clindamycin cream alternative. Trichomoniasis: nitroimidazole course plus partner therapy and abstinence until completion. Uncomplicated VVC: oral fluconazole or topical azoles. Pregnancy: use obstetric-approved regimens—avoid unsupervised high-dose oral fluconazole in the first trimester.

📋

Clinical Practice Considerations

Teach-back on alcohol avoidance with nitroimidazoles and expected metallic taste.
Document partner notification for trichomoniasis and retest intervals.
Recheck 1–2 weeks if moderate symptoms; sooner in pregnancy.
Escalate if two guideline-concordant courses fail—consider culture, resistant Candida, mixed infection or foreign body.

Bedside monitoring checklist

Temperature, heart rate, BP if any pelvic pain.
Document discharge character at each visit for trend.
Pregnancy status and gestation on every medication administration check.

⚠️

Possible Complications

Ascending infection (PID, perihepatitis), preterm labour associations with symptomatic BV in pregnancy, chronic pelvic pain from undertreated STIs, and psychosexual morbidity from recurrent symptoms.

🛡️

Prevention

Discourage douching, promote condom use with new partners, optimise glycaemic control in diabetes, complete antibiotic courses for trichomoniasis with verified partner treatment, and align yeast infection education with maintenance regimens only when specialist-directed.

📈

Prognosis and Outlook

Most uncomplicated episodes resolve with first-line therapy; recurrence reflects microbiome susceptibility, sexual networks or incomplete partner treatment rather than “treatment failure” alone.

👩‍⚕️

In Clinical Practice…

Chaperone-sensitive examinations, narrate each step of swabs, label specimens at bedside per local specimen-handling policy, and use neutral language when discussing sexual history to maintain therapeutic alliance.

🚨

When to Seek Emergency Care

🚨Immediate escalation

Hypotension, tachycardia, confusion or lactate elevation with pelvic symptoms.
Rigid abdomen, rebound guarding or absent bowel sounds.
Heavy vaginal bleeding with haemodynamic instability.

📚

NCLEX practice questions

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, matrix matching and cloze drops on the topic of vaginitis discharge triage, microscopy or NAAT sequencing, first-line therapy choices and Clinical Judgment Measurement Model cues for recognising PID masquerading as uncomplicated vaginal infection.

Unfolding case (Questions 1–3): Ms. T., 26, presents with 5 days of vulvar itch, thick white discharge, dysuria chiefly at the introitus, no fever. She finished a course of doxycycline 10 days ago for chlamydia (partner treated). Vaginal pH 4.2; KOH prep shows pseudohyphae. No cervical motion tenderness.

Question 1 · Type 1 — MCQ · Family A (Priority — FIRST)

What should the nurse do FIRST?

Empirically start oral metronidazole for presumed BV. Coordinate clinician-confirmed uncomplicated vulvovaginal candidiasis care: align oral or topical azole therapy per protocol, review recent antibiotic exposure, screen for hyperglycaemia risk, reinforce completion of prescribed antifungal course, document external dysuria versus pyuria if symptoms persist, and schedule early review if fever or pelvic pain develops. Discharge with reassurance only. Order broad-spectrum IV antibiotics.

Question 2 · Type 2 — SATA · Family C

Which findings support uncomplicated vulvovaginal candidiasis in Ms. T.? Select all that apply

Prominent vulvar pruritus. Thick adherent “cottage cheese” discharge. Vaginal pH ≤4.5. Motile flagellated organisms on saline wet mount. Pseudohyphae on KOH preparation. Recent oral antibiotic exposure.

Question 3 · Type 2 — SATA · Family E (Deterioration)

Telephone triage day 4 of fluconazole: Now fever 38.6°C, deep pelvic pain, nausea, chills—partner notes confusion.

Which actions reflect urgent deterioration / escalation judgement? Select all that apply

Advise paracetamol only and routine clinic in 1 week. Activate same-day obstetric or gynaecology emergency assessment for possible PID or sepsis. Obtain vital signs and document cervical motion tenderness if assessed. Continue oral fluconazole without reassessment. Prepare for sepsis bundle per facility policy if instability present. Ignore new neurocognitive change.

Question 4 · Type 1 — MCQ · Family F (Triage — who first?)

Four patients arrive simultaneously. Who should the nurse assess FIRST?

26-year-old with mild itch awaiting routine STI results. 32-year-old pregnant patient with fever, purulent discharge, fetal tachycardia. 40-year-old collecting metronidazole refill without symptoms. 55-year-old stable post-total hysterectomy for benign disease.

Question 5 · Type 8 — Matrix · Family G

Match each scenario to the initial pathway emphasis.

Scenario	Outpatient education / completion	Same-day clinician review	Emergency / sepsis pathway
Stable completed metronidazole for trichomoniasis, partner treated, asymptomatic
Persistent malodorous discharge after BV therapy, no fever
Febrile, hypotensive, purulent discharge and pelvic peritonism
First-dose oral fluconazole given, mild itch improving, afebrile

Swipe sideways on small screens.

Question 6 · Type 9 — Cloze · Family I

Confirmed trichomoniasis requires ; retesting is typically advised .

Answer key & rationale

Next step Timed NCLEX Next Gen–style scenarios on NurseOnShift